Select Study

Healthy men age 55 and older are needed for the largest-ever prostate cancer prevention study, launched by the National Cancer Institute (NCI) and Southwest Oncology Group (SWOG). The Selenium and Vitamin E Cancer Prevention Trial, or SELECT, will determine if these two dietary supplements can protect against prostate cancer, the most common form of cancer after skin cancer in men. During this year alone, prostate cancer will be diagnosed in about 198,100 Americans and more than 31,500 men are expected to die of the disease. Risk factors for the disease include being over age 55, being black, or having a father or brother with prostate cancer.

Selenium and vitamin E, both naturally occurring nutrients, are antioxidants. They are capable of neutralizing toxins known as "free radicals" that might otherwise damage the genetic material of cells and possibly lead to cancer. These nutrients were chosen for study because of the results of two other large cancer prevention trials that showed these antioxidants decreased the incidence of prostate cancer in men.

To find out if you are eligible for SELECT, please call the Baptist Cancer Institute at (904) 202-7073. For more information, visit the Select Selenium & Vitamin E Cancer Prevention Trial at: http://www.crab.org/select/
or the National Cancer Institute: NCI's website
or visit SWOG's website at http://swog.org and choose SELECT.